PubMed:2897793 / 131-425 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":294},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":294},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"DNA sequence polymorphisms (RFLPs) have been widely used as genetic markers for identification of the X chromosome that carries the mutation for Duchenne muscular dystrophy (DMD) in affected families, but serious limitations and pitfalls are associated with this approach [Darras et al., 1987]."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":154,"end":172},"obj":"HP_0003560"}],"text":"DNA sequence polymorphisms (RFLPs) have been widely used as genetic markers for identification of the X chromosome that carries the mutation for Duchenne muscular dystrophy (DMD) in affected families, but serious limitations and pitfalls are associated with this approach [Darras et al., 1987]."}

{"project":"PubCasesHPO","denotations":[{"id":"AB1","span":{"begin":154,"end":172},"obj":"HP:0003560"}],"text":"DNA sequence polymorphisms (RFLPs) have been widely used as genetic markers for identification of the X chromosome that carries the mutation for Duchenne muscular dystrophy (DMD) in affected families, but serious limitations and pitfalls are associated with this approach [Darras et al., 1987]."}

{"project":"PubCasesORDO","denotations":[{"id":"AB1","span":{"begin":145,"end":172},"obj":"ORDO:98896"},{"id":"AB2","span":{"begin":174,"end":177},"obj":"ORDO:98896"}],"namespaces":[{"prefix":"ORDO","uri":"http://www.orpha.net/ORDO/Orphanet_"}],"text":"DNA sequence polymorphisms (RFLPs) have been widely used as genetic markers for identification of the X chromosome that carries the mutation for Duchenne muscular dystrophy (DMD) in affected families, but serious limitations and pitfalls are associated with this approach [Darras et al., 1987]."}